A/Prof David Pattison

Convenor and Chair of the AANMS Theranostics Course & Case Library Committee

David underwent dual specialty training in both Endocrinology and Nuclear Medicine at Royal Melbourne Hospital, Austin Hospital and Peter MacCallum Cancer Centre in Melbourne.
He was appointed a staff specialist at Peter MacCallum Cancer Centre at the completion of his training and moved to Royal Brisbane & Women’s Hospital in 2016 where he is currently the Deputy Director of Department of Nuclear Medicine & Specialised PET Services, nuclear medicine lead for the RBWH radionuclide therapy service and supervises postgraduate students at University of Queensland.
His research interests are at the intersection of nuclear medicine & endocrinology - neuroendocrine tumours & thyroid cancer - and prostate cancer theranostics.
He has been a chief investigator on several large competitive grants for theranostics, including redifferentiation of radioactive iodine refractory thyroid cancer (I-FIRST $2.7 million MRFF 2021), prostate cancer (UpFrontPSMA $4 million Movember/Cancer Australia 2019) and merkel cell cancer (GoTHAM $1.8 million MRFF 2018).